Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding

American Journal of Health-System Pharmacy

Volumn 62, Issue SUPPL. 2, 2005, Pages

  Olsen, Keith M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Dosage; Drug administration routes; Gastrointestinal drugs; Gastrointestinal hemorrhage; Mortality; Ulcers

Indexed keywords

CIMETIDINE; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE;

ANAMNESIS; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; GASTROINTESTINAL ENDOSCOPY; HIGH RISK PATIENT; HUMAN; META ANALYSIS; PATIENT CARE; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; STOMACH ACID SECRETION; STOMACH PH; UPPER GASTROINTESTINAL BLEEDING;

EID: 18644370033     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/62.10_supplement_2.s18     Document Type: Conference Paper

References (32)

1. Kupfer Y, Cappell MS, Tessler S. Acute gastrointestinal bleeding in the intensive care unit. The intensivist's perspective. Gastroenterol Clin North Am. 2000; 29:275-307.
2. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med. 1994; 331:717-27.
3. Barkun A, Bardou M, Marshall JK; Non-variceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2003; 139:843-57.
4. Vorder Bruegge WF, Peura DA. Stress-related mucosal damage: review of drug therapy. J Clin Gastroenterol. 1990; 12(suppl 2):S35-40.
5. Li Y, Sha W, Nie Y et al. Effect of intragastric pH on control of peptic ulcer bleeding. J Gastroenterol Hepatol. 2000; 15:148-54.
6. Yacyshyn BR, Thomson AB. Critical review of acid suppression in nonvariceal, acute, upper gastrointestinal bleeding. Dig Dis. 2000; 18:117-28.
7. Leontiadis GI, McIntyre L, Sharma VK et al. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2004; (3):CD002094.
8. Rockall TA, Logan RF, Devlin HB et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996; 38:316-21.
9. Kollef MH, O'Brien JD, Zuckerman GR et al. BLEED: a classification tool to predict outcomes in patients with acute upper and lower gastrointestinal hemorrhage. Crit Care Med. 1997; 25:1125-32.
10. Silverstein FE, Gilbert DA, Tedesco FJ et al. The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc. 1981; 27:80-93.
11. Levine JE, Leontiadis GI, Sharma VK et al. Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther. 2002; 16:1137-42.
12. Collins R, Langman M. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med. 1985; 313:660-6.
13. Sung JJ, Chan FK, Lau JY et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med. 2003; 139:237-43.
14. Zuckerman G, Welch R, Douglas A et al. Controlled trial of medical therapy for active upper gastrointestinal bleeding and prevention of rebleeding. Am J Med. 1984; 76:361-6.
15. Birnie GG, Quigley EM, Allan G et al. A double-blind randomized trial of cimetidine in acute upper gastrointestinal bleeding. Scand J Gastroenterol. 1984; 19:885-8.
16. Walt RP, Cottrell J, Mann SG et al. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet. 1992; 340:1058-62.
17. Lin HJ, Lo WC, Lee FY et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med. 1998; 158:54-8.
18. Merki HS, Wilder-Smith CH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology. 1994; 106:60-4.
19. Gisbert JP, Gonzalez L, Calvet X et al. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther. 2001; 15:917-26.
20. Khuroo MS, Yattoo GN, Javid G et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med. 1997; 336:1054-8.
21. Kaviani MJ, Hashemi MR, Kazemifar AR et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial. Aliment Pharmacol Ther. 2003; 17:211-6.
22. Lau JY, Sung JJ, Lee KK et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000; 343:310-6.
23. Hasselgren G, Lind T, Lundell L et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol. 1997; 32:328-33.
24. Schaffalitzky de Muckadell OB, Havelund T, Harling H et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol. 1997; 32:320-7.
25. Daneshmend TK, Hawkey CJ, Langman MJ et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ. 1992; 304:143-7.
26. Orti E, Canelles P, Quiles F et al. Does the antisecretory agent used affect the evolution of upper digestive hemorrhage? Rev Esp Enferm Dig. 1995; 87:427-30.
27. Lanas A, Artal A, Blas JM et al. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin Gastroenterol. 1995; 21:103-6.
28. Villanueva C, Balanzo J, Torras X et al. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study. Endoscopy. 1995; 27:308-12.
29. Welage LS, Berardi RR. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. J Am Pharm Assoc (Wash). 2000; 40:52-62.
30. van Rensburg CJ, Hartmann M, Thorpe A et al. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. Am J Gastroenterol. 2003; 98:2635-41.
31. Barkun A, Racz I, van Rensburg et al. Prevention of peptic ulcer rebleeding using continous infusion of pantoprazole vs. ranitidine: a multicenter, multinational, randomized, double-blind, parallel-group comparision. Gastroenterology. 2004; 126:A78. Abstract.
32. Hsu Pi, Lo GH, Lo CC et al. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol. 2004; 10:3666-9.